ALKERMES | 销售

股票价格

33.16

每天变化

-0.13 -0.39%

每月一次

8.30%

每年

-7.61%

Q1 预测

32.16

金融业

USD

USD 2.33B

现金及等价物

USD 616.45M

USD 51.59M

USD 1.74B

USD 474.36M

USD 71.6M

股息收益率

0

USD 89.08M

USD 121.55M

1.8K

EPS每股收益

USD 0.49

股本和储备

USD 1.73B

USD 265.83M

债务利息支出

USD 4.65M

USD 11.94M

USD 285.82M

USD 5.39B

USD 82.76M

USD 1.73B

USD 89.08M

普通股股本

USD 165.1M

USD 14.9

USD 100.74M

USD 394.2M

销售和管理费用

USD 171.77M

USD 191M

贸易债权人

USD 68M

应收帐款人

USD 355.11M

	销售	更改		日
AbbVie	USD 16.62B		840M	2025-12
Acadia Pharmaceuticals	USD 278.6M		14M	2025-09
ALKERMES	USD 394.2M		3.5M	2025-09
Amgen	USD 9.9B		340M	2025-12
Biogen	USD 2.28B		250M	2025-12
BioMarin Pharmaceutical	USD 776M		49M	2025-09
Bristol-Myers Squibb	USD 12.5B		300M	2025-12
Coherus Biosciences	USD 7.6M		46.54M	2025-03
Eli Lilly	USD 19.3B		1.7B	2025-12
Gilead Sciences	USD 7.93B		130M	2025-12
Heron Therapeutics	USD 32.81M		3.21M	2024-09
Ionis Pharmaceuticals	USD 157M		295M	2025-09
J&J	USD 24.6B		610M	2025-12
Merck	USD 16.4B		880M	2025-12
Minerva Neurosciences	USD 0		0	2024-09
Nektar Therapeutics	USD 24.12M		635K	2024-09
Neurocrine Biosciences	USD 805.5M		10.6M	2025-12
Otsuka Holdings	JPY 650.15B		12.17B	2025-12
Pfizer	USD 17.58B		880M	2025-12
Regeneron Pharmaceuticals	USD 3.88B		130M	2025-12
Vertex Pharmaceuticals	USD 3.19B		110M	2025-12

ALKERMES 销售 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.